Latest filing published 27 Mar 2016 for Cipher Pharmaceuticals Inc..
No signal scores available.
All filings by Louis Blythe on record concern Cipher Pharmaceuticals Inc. Between 14 May 2015 and 22 March 2016, the trades on record add up to 3 filings.
No open-market purchase appears, only 1 sale. The amount is not disclosed for 1 filing. Besides market trades, the filings include 1 option exercise. Since January 2016: no purchases and 1 sale on the market.
Most recently, on 27 March 2016, the filings show an open-market sale in Cipher Pharmaceuticals Inc. Filings reach the SEDI feed a median of 5 days after the trade. Until a filing is published, the market cannot know about the trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations